[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368185-105":59,"doc-detail-368185-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","assessing-the-rise-in-papillary-thyroid-cancer-incidence-a-38-year-australian-study-investigating-who-classification-influence","Assessing the Rise in Papillary Thyroid Cancer Incidence - A 38-Year Australian Study Investigating WHO Classification Influence","","Thyroid cancer incidence has increased markedly worldwide. This Australian descriptive epidemiological study examined how changes in papillary thyroid carcinoma (PTC) subtypes and World Health Organisation (WHO) endocrine tumor classification influenced overall thyroid cancer incidence recorded in Australia from 1982 to 2019. Joinpoint regression assessed temporal trends for PTC subtypes and compared results with WHO classification changes. Findings showed increases in classic PTC and thyroid microcarcinomas after 2003, a decline in the follicular variant from 2015, and classification-aligned trend shifts in 2004 and 2016/17. Even after accounting for these changes, PTC rose substantially over three decades, indicating a true increase beyond improved reporting.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/assessing-the-rise-in-papillary-thyroid-cancer-incidence-a-38-year-australian-study-investigating-who-classification-influence/368185/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/assessing-the-rise-in-papillary-thyroid-cancer-incidence-a-38-year-australian-study-investigating-who-classification-influence/368185.png","ImageObject",300,407,{"name":92,"@type":93},"Olivia Brown","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the main goal of the 38-year Australian study?","Question",{"text":112,"@type":113},"To evaluate how papillary thyroid carcinoma subtype patterns and WHO endocrine tumor classification changes affected overall thyroid cancer incidence in Australia from 1982 to 2019.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which PTC subtypes showed increasing or decreasing incidence trends?",{"text":117,"@type":113},"Classic PTC increased throughout the 38-year period, thyroid microcarcinomas increased after 2003, and the follicular variant began declining in 2015.",{"name":119,"@type":110,"acceptedAnswer":120},"Does the study attribute rising thyroid cancer incidence only to WHO classification changes?",{"text":121,"@type":113},"No. Even after accounting for WHO-driven classification shifts, significant increases in PTC over the last three decades were still observed, indicating a genuine rise rather than only improved reporting and diagnostics.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},368185,1790209883,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},16904993612988,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Journal of Epidemiology and Global Health (2025) 15:9  \n[https://doi.org/10.1007/s44197-025-00354-5](https://doi.org/10.1007/s44197-025-00354-5)  \nRESEARCH ARTICLE  \nAssessing the Rise in Papillary Thyroid Cancer Incidence: A 38-Year Australian Study Investigating WHO Classification Influence  \nSteven Weller1,2 · Cordia Chu1 · Alfred King-yin Lam1,3  \nReceived: 16 September 2024 / Accepted: 17 January 2025 © The Author(s) 2025  \nAbstract  \nThe incidence of thyroid cancer has shown marked increases globally over recent decades. This study investigated how the incidence of papillary thyroid carcinoma (PTC) subtypes and World Health Organisation (WHO) endocrine tumour classification changes have affected overall thyroid cancer incidence recorded in Australia. Using incidence data from the Australian Institute of Health and Welfare cancer registry (spanning 1982 to 2019), this descriptive epidemiological study employed joinpoint regression analysis to assess temporal trends in thyroid carcinoma incidence, focusing on PTC. Results were then compared with WHO endocrine tumour classification changes over the same period. The results showed increasing trends for the classic PTC subtype over the entire 38-year period and for thyroid microcarcinomas post-2003, while a declining trend for the follicular variant of PTC was observed commencing in 2015. Examination of PTC incidence also revealed distinct changes in trends that align with the WHO classification of papillary microcarcinoma as a subtype in 2004 and the reclassification of some encapsulated follicular variant of PTCs to non-invasive follicular thyroid neoplasms with papillary-like nuclear features (NIFTP) in 2016/17. Even when taking these WHO classification changes into account, significant increases in PTC over the last three decades are observed. These findings underscore the shifts in classification driven by improving diagnostic clarity influencing thyroid carcinoma incidence patterns. However, thyroid carcinoma cases in Australia have dramatically increased over the last three decades independent of WHO classification changes, suggesting a genuine increase rather than simply being a direct consequence of improved reporting and diagnostics.  \nKeywords Thyroid Carcinoma · Papillary Thyroid Carcinoma · Australia · WHO Classification · Endocrine Tumours · Global cancer Incidence Trends  \n1 Introduction  \nThe incidence of many cancers is increasing globally, with some cancers outpacing others over the past two decades. Similarly, cancer incidence in Australia, when compared to the global cancer profile, shares many of the same top 20  \n􀀍 Alfred King-yin Lam[a.lam@griffith.edu.au](a.lam@griffith.edu.au)  \n1 Centre of Environment and Population Health, School of Medicine and Dentistry, Griffith University, Nathan, QLD 4111, Australia  \n2 Oceania Radiofrequency Scientific Advisory Association Inc.(ORSAA), Scarborough, QLD 4020, Australia  \n3 Department of Pathology, School of Medicine and Dentistry, Griffith University, Gold Coast Campus, Gold Coast, QLD 4222, Australia  \ncancers but in a different ranking order (Fig. Supp-1a/b)1. Some of the cancer ranking differences are attributable to cancer screening programs, environmental factors, lifestyle choices, and governmental policies adopted in Australia compared with the rest ofthe world.  \nWhen reviewing the profile of the top 20 cancer incidence data, one specific cancer stands out above all others, thyroid cancer, warranting further investigation due to the rapid increase seen from both a global and an Australian perspective (Fig. Supp-2a/b) .  \nA recent study investigating thyroid cancer in the United States (US) suggested that approximately 1.2% of the US population would be diagnosed with thyroid cancer within their lifetime and that the overall incidence has increased over the past four decades by 313%[1] .  \n1 Note: all figures and tables in italics that are identified with the prefix – Supp can be found in the supplementa","cbCairMz24NXbcDt","https://ap.wps.com/l/cbCairMz24NXbcDt","pdf",1350866,12,"English","# Abstract\n# Introduction\n# Papillary Thyroid Carcinoma and its Subtypes","[{\"question\":\"What was the main goal of the 38-year Australian study?\",\"answer\":\"To evaluate how papillary thyroid carcinoma subtype patterns and WHO endocrine tumor classification changes affected overall thyroid cancer incidence in Australia from 1982 to 2019.\"},{\"question\":\"Which PTC subtypes showed increasing or decreasing incidence trends?\",\"answer\":\"Classic PTC increased throughout the 38-year period, thyroid microcarcinomas increased after 2003, and the follicular variant began declining in 2015.\"},{\"question\":\"Does the study attribute rising thyroid cancer incidence only to WHO classification changes?\",\"answer\":\"No. Even after accounting for WHO-driven classification shifts, significant increases in PTC over the last three decades were still observed, indicating a genuine rise rather than only improved reporting and diagnostics.\"}]","Assessing the Rise in Papillary Thyroid Cancer Incidence - A 38-Year Australian Study Investigating WHO Classification Influence | PDF",1790175477,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/277d143139aa6e3c9279d84fc1d5a923.webp",983,1305,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c5a13e1f0d4a7a1426dba83f7c6a5c98.webp",982,1304,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9f0ce43ff792e8370a02ba8a6f72508d.webp",981,1303,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a401fcbe284c40c9fda7374d46da9481.webp",980,1301]